Janet A Fairley Christian L Baum Debra S Brandt Kelly A N Messingham
10.1016/j.jaci.2008.11.035
J Allergy Clin Immunol
2009 Mar;123(3):704-5.
author_manuscript
https://pubmed.ncbi.nlm.nih.gov/19152970/
Anti-Allergic Agents / therapeutic use Antibodies, Monoclonal / therapeutic use Autoantibodies / immunology Autoimmunity / immunology Immunoglobulin E / immunology Pemphigoid, Bullous / drug therapy
Anti-Allergic Agents / therapeutic use Antibodies, Monoclonal / therapeutic use Autoantibodies / immunology Autoimmunity / immunology Immunoglobulin E / immunology Pemphigoid, Bullous / drug therapy Case Reports Letter Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Aged Antibodies, Anti-Idiotypic Antibodies, Monoclonal, Humanized Autoantibodies / blood Autoantigens / immunology Autoantigens / metabolism Female Humans Immunoglobulin E / blood Non-Fibrillar Collagens / immunology Non-Fibrillar Collagens / metabolism Omalizumab Pemphigoid, Bullous / immunology Pemphigoid, Bullous / pathology Anti-Allergic Agents Antibodies, Anti-Idiotypic Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Autoantibodies Autoantigens Non-Fibrillar Collagens collagen type XVII Omalizumab Immunoglobulin E
PMC4784096
19152970
Pathogenicity of IgE in autoimmunity: successful treatment of bullous pemphigoid with omalizumab
2009